{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T20:16:56Z","timestamp":1793132216258,"version":"4.5.0"},"reference-count":108,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/j.jaut.2013.07.001","type":"journal-article","created":{"date-parts":[[2013,9,24]],"date-time":"2013-09-24T21:02:33Z","timestamp":1380056553000},"page":"66-73","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":152,"special_numbering":"C","title":["Role of the intestinal microbiome in liver disease"],"prefix":"10.1016","volume":"46","author":[{"given":"Jorge","family":"Henao-Mejia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eran","family":"Elinav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph A.","family":"Thaiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Licona-Limon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard A.","family":"Flavell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaut.2013.07.001_bib1","article-title":"Role of gut microbiota in liver diseases","author":"Miyake","year":"2012","journal-title":"Hepatol Res"},{"key":"10.1016\/j.jaut.2013.07.001_bib2","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nature11551","article-title":"Reciprocal interactions of the intestinal microbiota and immune system","volume":"489","author":"Maynard","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.jaut.2013.07.001_bib3","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/nature11552","article-title":"Functional interactions between the gut microbiota and host metabolism","volume":"489","author":"Tremaroli","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.jaut.2013.07.001_bib4","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/nature11550","article-title":"Diversity, stability and resilience of the human gut microbiota","volume":"489","author":"Lozupone","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.jaut.2013.07.001_bib5","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/nature11319","article-title":"Gut microbiota composition correlates with diet and health in the elderly","volume":"488","author":"Claesson","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.jaut.2013.07.001_bib6","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/nature07540","article-title":"A\u00a0core gut microbiome in obese and lean twins","volume":"457","author":"Turnbaugh","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.jaut.2013.07.001_bib7","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1146\/annurev-physiol-020911-153330","article-title":"Toll-like receptor\u2013gut microbiota interactions: perturb at your own risk!","volume":"74","author":"Carvalho","year":"2012","journal-title":"Annu Rev Physiol"},{"key":"10.1016\/j.jaut.2013.07.001_bib8","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1126\/science.1172747","article-title":"Innate and adaptive immunity cooperate flexibly to maintain host\u2013microbiota mutualism","volume":"325","author":"Slack","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.jaut.2013.07.001_bib9","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1097\/00062752-200701000-00010","article-title":"Toll-like receptors and innate immunity in gut homeostasis and pathology","volume":"14","author":"Michelsen","year":"2007","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.jaut.2013.07.001_bib10","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1002\/hep.21482","article-title":"Regulation of Toll-like receptor-2 expression in chronic hepatitis B by the precore protein","volume":"45","author":"Visvanathan","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2013.07.001_bib11","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/hep.24625","article-title":"Toll-like receptor 2-mediated innate immune response in human nonparenchymal liver cells toward adeno-associated viral vectors","volume":"55","author":"Hosel","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2013.07.001_bib12","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.jhep.2009.06.020","article-title":"Toll-like receptor activated human and murine hepatic stellate cells are potent regulators of hepatitis C virus replication","volume":"51","author":"Wang","year":"2009","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jaut.2013.07.001_bib13","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.1478-3231.2006.01254.x","article-title":"Human intrahepatic biliary epithelial cells function in innate immunity by producing IL-6 and IL-8 via the TLR4-NF-kappaB and -MAPK signaling pathways","volume":"26","author":"Yokoyama","year":"2006","journal-title":"Liver Int"},{"key":"10.1016\/j.jaut.2013.07.001_bib14","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jaut.2005.05.003","article-title":"Hepatic expression of toll-like receptor 4 in primary biliary cirrhosis","volume":"25","author":"Wang","year":"2005","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.jaut.2013.07.001_bib15","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/ni.1863","article-title":"The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors","volume":"11","author":"Kawai","year":"2010","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jaut.2013.07.001_bib16","doi-asserted-by":"crossref","first-page":"G516","DOI":"10.1152\/ajpgi.00537.2010","article-title":"Innate immunity in alcoholic liver disease","volume":"300","author":"Gao","year":"2011","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.jaut.2013.07.001_bib17","first-page":"1452","article-title":"Nonalcoholic fatty liver disease in humans is associated with increased plasma endotoxin and plasminogen activator inhibitor 1 concentrations and with fructose intake","volume":"138","author":"Thuy","year":"2008","journal-title":"J\u00a0Nutr"},{"key":"10.1016\/j.jaut.2013.07.001_bib18","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1111\/j.1478-3231.2011.02635.x","article-title":"Enhanced innate immune responsiveness and intolerance to intestinal endotoxins in human biliary epithelial cells contributes to chronic cholangitis","volume":"31","author":"Mueller","year":"2011","journal-title":"Liver Int"},{"key":"10.1016\/j.jaut.2013.07.001_bib19","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1002\/hep.24552","article-title":"Nuclear factor high-mobility group box1 mediating the activation of Toll-like receptor 4 signaling in hepatocytes in the early stage of nonalcoholic fatty liver disease in mice","volume":"54","author":"Li","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2013.07.001_bib20","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/hep.21695","article-title":"A\u00a07 gene signature identifies the risk of developing cirrhosis in patients with chronic hepatitis C","volume":"46","author":"Huang","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2013.07.001_bib21","doi-asserted-by":"crossref","first-page":"4506","DOI":"10.4049\/jimmunol.1200202","article-title":"The Asp299Gly polymorphism alters TLR4 signaling by interfering with recruitment of MyD88 and TRIF","volume":"188","author":"Figueroa","year":"2012","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jaut.2013.07.001_bib22","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1053\/j.gastro.2010.08.020","article-title":"Type I interferons protect from Toll-like receptor 9-associated liver injury and regulate IL-1 receptor antagonist in mice","volume":"140","author":"Petrasek","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaut.2013.07.001_bib23","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1002\/hep.24059","article-title":"Interferon regulatory factor 3 and type I interferons are protective in alcoholic liver injury in mice by way of crosstalk of parenchymal and myeloid cells","volume":"53","author":"Petrasek","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2013.07.001_bib24","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1038\/nm1663","article-title":"TLR4 enhances TGF-beta signaling and hepatic fibrosis","volume":"13","author":"Seki","year":"2007","journal-title":"Nat Med"},{"key":"10.1016\/j.jaut.2013.07.001_bib25","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/nature10809","article-title":"Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity","volume":"482","author":"Henao-Mejia","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.jaut.2013.07.001_bib26","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1158\/1940-6207.CAPR-11-0364","article-title":"Gut-derived lipopolysaccharide promotes T-cell-mediated hepatitis in mice through Toll-like receptor 4","volume":"5","author":"Lin","year":"2012","journal-title":"Cancer Prev Res (Phila)"},{"key":"10.1016\/j.jaut.2013.07.001_bib27","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/ni.2257","article-title":"Inflammasomes: far beyond inflammation","volume":"13","author":"Henao-Mejia","year":"2012","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jaut.2013.07.001_bib28","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/nature10759","article-title":"Inflammasomes in health and disease","volume":"481","author":"Strowig","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.jaut.2013.07.001_bib29","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.coi.2009.12.004","article-title":"The inflammasomes: mechanisms of activation and function","volume":"22","author":"Latz","year":"2010","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.jaut.2013.07.001_bib30","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.immuni.2011.05.007","article-title":"Regulation of the antimicrobial response by NLR proteins","volume":"34","author":"Elinav","year":"2011","journal-title":"Immunity"},{"key":"10.1016\/j.jaut.2013.07.001_bib31","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/1476-9255-9-49","article-title":"Expression analysis of inflammasomes in experimental models of inflammatory and fibrotic liver disease","volume":"9","author":"Boaru","year":"2012","journal-title":"J\u00a0Inflamm (Lond)"},{"key":"10.1016\/j.jaut.2013.07.001_bib32","first-page":"305","article-title":"Acetaminophen-induced hepatotoxicity in mice is dependent on Tlr9 and the Nalp3 inflammasome","volume":"119","author":"Imaeda","year":"2009","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jaut.2013.07.001_bib33","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.taap.2010.07.004","article-title":"Role of caspase-1 and interleukin-1beta in acetaminophen-induced hepatic inflammation and liver injury","volume":"247","author":"Williams","year":"2010","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.jaut.2013.07.001_bib34","doi-asserted-by":"crossref","first-page":"G1248","DOI":"10.1152\/ajpgi.90223.2008","article-title":"Inflammasome-mediated regulation of hepatic stellate cells","volume":"296","author":"Watanabe","year":"2009","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.jaut.2013.07.001_bib35","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1089\/hum.2010.145","article-title":"Gene silencing of NALP3 protects against liver ischemia-reperfusion injury in mice","volume":"22","author":"Zhu","year":"2011","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.jaut.2013.07.001_bib36","doi-asserted-by":"crossref","first-page":"641865","DOI":"10.1155\/2010\/641865","article-title":"The TLR4\/TRIF-mediated activation of NLRP3 inflammasome underlies endotoxin-induced liver injury in mice","volume":"2010","author":"Tsutsui","year":"2010","journal-title":"Gastroenterol Res Pract"},{"key":"10.1016\/j.jaut.2013.07.001_bib37","doi-asserted-by":"crossref","first-page":"20459","DOI":"10.1073\/pnas.1010337107","article-title":"Schistosoma mansoni triggers Dectin-2, which activates the Nlrp3 inflammasome and alters adaptive immune responses","volume":"107","author":"Ritter","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaut.2013.07.001_bib38","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/hep.24341","article-title":"Fatty acid and endotoxin activate inflammasomes in mouse hepatocytes that release danger signals to stimulate immune cells","volume":"54","author":"Csak","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2013.07.001_bib39","doi-asserted-by":"crossref","first-page":"4772","DOI":"10.3748\/wjg.v17.i43.4772","article-title":"Lipopolysaccharide induces and activates the Nalp3 inflammasome in the liver","volume":"17","author":"Ganz","year":"2011","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jaut.2013.07.001_bib40","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1126\/science.1179721","article-title":"Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5","volume":"328","author":"Vijay-Kumar","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.jaut.2013.07.001_bib41","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1084\/jem.20120504","article-title":"Familial transmission rather than defective innate immunity shapes the distinct intestinal microbiota of TLR-deficient mice","volume":"209","author":"Ubeda","year":"2012","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jaut.2013.07.001_bib42","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.cell.2011.04.022","article-title":"NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis","volume":"145","author":"Elinav","year":"2011","journal-title":"Cell"},{"issue":"Suppl.\u00a03","key":"10.1016\/j.jaut.2013.07.001_bib43","doi-asserted-by":"crossref","first-page":"S206","DOI":"10.1016\/S1590-8658(10)60507-5","article-title":"The changing pattern of epidemiology in hepatocellular carcinoma","volume":"42","author":"Nordenstedt","year":"2010","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.jaut.2013.07.001_bib44","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.ccr.2012.02.007","article-title":"Promotion of hepatocellular carcinoma by the intestinal microbiota and TLR4","volume":"21","author":"Dapito","year":"2012","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jaut.2013.07.001_bib45","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1055\/s-2006-933560","article-title":"Primary sclerosing cholangitis: epidemiology, natural history, and prognosis","volume":"26","author":"Levy","year":"2006","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jaut.2013.07.001_bib46","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.cgh.2011.11.010","article-title":"Primary sclerosing cholangitis and disease distribution in inflammatory bowel disease","volume":"10","author":"O'Toole","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jaut.2013.07.001_bib47","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1002\/ibd.21569","article-title":"Clinical characteristics of ulcerative colitis associated with primary sclerosing cholangitis in Korea","volume":"17","author":"Ye","year":"2011","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.jaut.2013.07.001_bib48","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/j.1440-1746.1993.tb01506.x","article-title":"Prevalence of primary sclerosing cholangitis and other liver diseases in Japanese patients with chronic ulcerative colitis","volume":"8","author":"Hashimoto","year":"1993","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.jaut.2013.07.001_bib49","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.cgh.2008.03.016","article-title":"Increased risk of primary sclerosing cholangitis and ulcerative colitis in first-degree relatives of patients with primary sclerosing cholangitis","volume":"6","author":"Bergquist","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jaut.2013.07.001_bib50","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1016\/j.gastro.2003.07.011","article-title":"Incidence, clinical spectrum, and outcomes of primary sclerosing cholangitis in a United States community","volume":"125","author":"Bambha","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaut.2013.07.001_bib51","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1007\/s00534-010-0319-8","article-title":"Clinical characteristics of inflammatory bowel disease associated with primary sclerosing cholangitis","volume":"18","author":"Sano","year":"2011","journal-title":"J\u00a0Hepatobiliary Pancreat Sci"},{"key":"10.1016\/j.jaut.2013.07.001_bib52","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1097\/PAS.0b013e318196d018","article-title":"Pathologic features of ulcerative colitis in patients with primary sclerosing cholangitis: a case\u2013control study","volume":"33","author":"Joo","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.jaut.2013.07.001_bib53","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jhep.2009.01.023","article-title":"Influence of dominant bile duct stenoses and biliary infections on outcome in primary sclerosing cholangitis","volume":"51","author":"Rudolph","year":"2009","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jaut.2013.07.001_bib54","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1002\/hep.1840170310","article-title":"Prevalence and characterization of neutrophil cytoplasmic antibodies in autoimmune liver diseases","volume":"17","author":"Mulder","year":"1993","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2013.07.001_bib55","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1002\/hep.510280207","article-title":"Atypical antineutrophil cytoplasmic antibodies with perinuclear fluorescence in chronic inflammatory bowel diseases and hepatobiliary disorders colocalize with nuclear lamina proteins","volume":"28","author":"Terjung","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2013.07.001_bib56","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1136\/gut.2008.157818","article-title":"p-ANCAs in autoimmune liver disorders recognise human beta-tubulin isotype 5 and cross-react with microbial protein FtsZ","volume":"59","author":"Terjung","year":"2010","journal-title":"Gut"},{"issue":"Suppl.\u00a01","key":"10.1016\/j.jaut.2013.07.001_bib57","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1038\/modpathol.3800684","article-title":"Autoimmune liver disease: overlap and outliers","volume":"20","author":"Washington","year":"2007","journal-title":"Mod Pathol"},{"key":"10.1016\/j.jaut.2013.07.001_bib58","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/S0140-6736(89)92034-5","article-title":"Relation between Escherichia coli R(rough)-forms in gut, lipid A in liver, and primary biliary cirrhosis","volume":"2","author":"Hopf","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/j.jaut.2013.07.001_bib59","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0168-8278(03)00501-4","article-title":"Microbial mimics are major targets of crossreactivity with human pyruvate dehydrogenase in primary biliary cirrhosis","volume":"40","author":"Bogdanos","year":"2004","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jaut.2013.07.001_bib60","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/hep.20788","article-title":"Primary biliary cirrhosis is characterized by IgG3 antibodies cross-reactive with the major mitochondrial autoepitope and its Lactobacillus mimic","volume":"42","author":"Bogdanos","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2013.07.001_bib61","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1053\/jhep.2003.50446","article-title":"Patients with primary biliary cirrhosis react against a ubiquitous xenobiotic-metabolizing bacterium","volume":"38","author":"Selmi","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2013.07.001_bib62","doi-asserted-by":"crossref","first-page":"137","DOI":"10.7326\/0003-4819-126-2-199701150-00008","article-title":"Nonalcoholic steatohepatitis","volume":"126","author":"Sheth","year":"1997","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jaut.2013.07.001_bib63","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/S0025-6196(24)00530-5","article-title":"Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease","volume":"55","author":"Ludwig","year":"1980","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jaut.2013.07.001_bib64","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1053\/jhep.2003.50161","article-title":"Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome","volume":"37","author":"Marchesini","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2013.07.001_bib65","doi-asserted-by":"crossref","first-page":"734","DOI":"10.2337\/dc06-1539","article-title":"Spectrum of liver disease in type 2 diabetes and management of patients with diabetes and liver disease","volume":"30","author":"Tolman","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jaut.2013.07.001_bib66","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.jhep.2007.04.012","article-title":"Nonalcoholic fatty liver disease in women with polycystic ovary syndrome","volume":"47","author":"Cerda","year":"2007","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jaut.2013.07.001_bib67","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1002\/hep.510290347","article-title":"Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease","volume":"29","author":"Caldwell","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2013.07.001_bib68","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/S0168-8278(02)00099-5","article-title":"Hepatocellular carcinoma in patients with non-alcoholic steatohepatitis","volume":"37","author":"Shimada","year":"2002","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jaut.2013.07.001_bib69","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/0016-5085(95)90724-6","article-title":"Prognosis in nonalcoholic steatohepatitis","volume":"108","author":"Propst","year":"1995","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaut.2013.07.001_bib70","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1002\/hep.22246","article-title":"Cirrhosis and liver failure in nonalcoholic fatty liver disease: molehill or mountain?","volume":"47","author":"Charlton","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2013.07.001_bib71","first-page":"583","article-title":"Nonalcoholic fatty liver disease","volume":"99","author":"Hjelkrem","year":"2008","journal-title":"Minerva Med"},{"key":"10.1016\/j.jaut.2013.07.001_bib72","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/S0016-5085(98)70599-2","article-title":"Steatohepatitis: a tale of two \u201chits\u201d?","volume":"114","author":"Day","year":"1998","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaut.2013.07.001_bib73","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1053\/gast.2001.23256","article-title":"Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities","volume":"120","author":"Sanyal","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaut.2013.07.001_bib74","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.cgh.2011.03.020","article-title":"Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008","volume":"9","author":"Younossi","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jaut.2013.07.001_bib75","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1038\/nature05414","article-title":"An obesity-associated gut microbiome with increased capacity for energy harvest","volume":"444","author":"Turnbaugh","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.jaut.2013.07.001_bib76","doi-asserted-by":"crossref","first-page":"11070","DOI":"10.1073\/pnas.0504978102","article-title":"Obesity alters gut microbial ecology","volume":"102","author":"Ley","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaut.2013.07.001_bib77","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1038\/4441022a","article-title":"Microbial ecology: human gut microbes associated with obesity","volume":"444","author":"Ley","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.jaut.2013.07.001_bib78","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1126\/science.1198719","article-title":"Diet drives convergence in gut microbiome functions across mammalian phylogeny and within humans","volume":"332","author":"Muegge","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.jaut.2013.07.001_bib79","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nature11450","article-title":"A\u00a0metagenome-wide association study of gut microbiota in type 2 diabetes","volume":"490","author":"Qin","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.jaut.2013.07.001_bib80","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/nature09944","article-title":"Enterotypes of the human gut microbiome","volume":"473","author":"Arumugam","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.jaut.2013.07.001_bib81","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1126\/science.1208344","article-title":"Linking long-term dietary patterns with gut microbial enterotypes","volume":"334","author":"Wu","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.jaut.2013.07.001_bib82","doi-asserted-by":"crossref","first-page":"14691","DOI":"10.1073\/pnas.1005963107","article-title":"Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa","volume":"107","author":"De Filippo","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaut.2013.07.001_bib83","article-title":"Intestinal microbiota determines development of non-alcoholic fatty liver disease in mice","author":"Le Roy","year":"2012","journal-title":"Gut"},{"key":"10.1016\/j.jaut.2013.07.001_bib84","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/0016-5085(93)90864-9","article-title":"Hepatobiliary complications of total parenteral nutrition","volume":"104","author":"Quigley","year":"1993","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaut.2013.07.001_bib85","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1055\/s-2007-985070","article-title":"Intestinal failure-associated liver disease: management and treatment strategies past, present, and future","volume":"27","author":"Carter","year":"2007","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jaut.2013.07.001_bib86","first-page":"349","article-title":"Non-alcoholic steatohepatitis associated with small intestinal diverticulosis and bacterial overgrowth","volume":"36","author":"Nazim","year":"1989","journal-title":"Hepatogastroenterology"},{"issue":"Suppl.\u00a01","key":"10.1016\/j.jaut.2013.07.001_bib87","doi-asserted-by":"crossref","first-page":"S80","DOI":"10.1093\/clinids\/6.Supplement_1.S80","article-title":"Jejunoileal bypass: change in the flora of the small intestine and its clinical impact","volume":"6","author":"Corrodi","year":"1984","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.jaut.2013.07.001_bib88","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1159\/000198705","article-title":"Effect of antibiotics in the prevention of jejunoileal bypass-induced liver dysfunction","volume":"23","author":"Vanderhoof","year":"1982","journal-title":"Digestion"},{"key":"10.1016\/j.jaut.2013.07.001_bib89","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1177\/0148607192016006529","article-title":"Polymyxin B reduces total parenteral nutrition-associated hepatic steatosis by its antibacterial activity and by blocking deleterious effects of lipopolysaccharide","volume":"16","author":"Pappo","year":"1992","journal-title":"J\u00a0Parenter Enteral Nutr"},{"key":"10.1016\/j.jaut.2013.07.001_bib90","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s11695-007-9398-2","article-title":"High prevalence of small intestinal bacterial overgrowth in patients with morbid obesity: a contributor to severe hepatic steatosis","volume":"18","author":"Sabate","year":"2008","journal-title":"Obes Surg"},{"key":"10.1016\/j.jaut.2013.07.001_bib91","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1002\/hep.22848","article-title":"Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease","volume":"49","author":"Miele","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2013.07.001_bib92","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/j.1365-2036.2005.02562.x","article-title":"Ciprofloxacin suppresses bacterial overgrowth, increases fasting insulin but does not correct low acylated ghrelin concentration in non-alcoholic steatohepatitis","volume":"22","author":"Sajjad","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jaut.2013.07.001_bib93","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1136\/gut.48.2.206","article-title":"The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumour necrosis factor alpha in the pathogenesis of non-alcoholic steatohepatitis","volume":"48","author":"Wigg","year":"2001","journal-title":"Gut"},{"key":"10.1016\/j.jaut.2013.07.001_bib94","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1002\/hep.510250636","article-title":"Ammonia and GABA-ergic neurotransmission: interrelated factors in the pathogenesis of hepatic encephalopathy","volume":"25","author":"Basile","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2013.07.001_bib95","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1055\/s-2007-1007198","article-title":"Spontaneous bacterial peritonitis","volume":"17","author":"Guarner","year":"1997","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jaut.2013.07.001_bib96","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1097\/00042737-199907000-00013","article-title":"Intestinal permeability in liver cirrhosis: relationship with severe septic complications","volume":"11","author":"Campillo","year":"1999","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.jaut.2013.07.001_bib97","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1136\/gut.2004.048181","article-title":"Infection, coagulation, and variceal bleeding in cirrhosis","volume":"54","author":"Thalheimer","year":"2005","journal-title":"Gut"},{"key":"10.1016\/j.jaut.2013.07.001_bib98","first-page":"1488","article-title":"Bacterial infection and acute bleeding from upper gastrointestinal tract in patients with liver cirrhosis","volume":"52","author":"Husova","year":"2005","journal-title":"Hepatogastroenterology"},{"key":"10.1016\/j.jaut.2013.07.001_bib99","doi-asserted-by":"crossref","first-page":"2962","DOI":"10.1111\/j.1572-0241.2001.04668.x","article-title":"Small intestinal bacterial overgrowth in patients with cirrhosis: prevalence and relation with spontaneous bacterial peritonitis","volume":"96","author":"Bauer","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jaut.2013.07.001_bib100","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1111\/j.1572-0241.2003.07475.x","article-title":"Small intestinal motility disturbances and bacterial overgrowth in patients with liver cirrhosis and portal hypertension","volume":"98","author":"Gunnarsdottir","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jaut.2013.07.001_bib101","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1007\/BF01297092","article-title":"Antibacterial activity of bile salts against common biliary pathogens. Effects of hydrophobicity of the molecule and in the presence of phospholipids","volume":"38","author":"Sung","year":"1993","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jaut.2013.07.001_bib102","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1111\/j.1365-2036.2009.04211.x","article-title":"Review article: the modern management of hepatic encephalopathy","volume":"31","author":"Bajaj","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"issue":"Suppl.\u00a01","key":"10.1016\/j.jaut.2013.07.001_bib103","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1746-6342.2006.03217.x","article-title":"Review article: bacterial flora and pathogenesis in hepatic encephalopathy","volume":"25","author":"Williams","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jaut.2013.07.001_bib104","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/ajg.2010.455","article-title":"Rifaximin improves psychometric performance and health-related quality of life in patients with minimal hepatic encephalopathy (the RIME Trial)","volume":"106","author":"Sidhu","year":"2011","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jaut.2013.07.001_bib105","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1053\/j.gastro.2010.08.061","article-title":"Rifaximin improves driving simulator performance in a randomized trial of patients with minimal hepatic encephalopathy","volume":"140","author":"Bajaj","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaut.2013.07.001_bib106","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1056\/NEJMoa0907893","article-title":"Rifaximin treatment in hepatic encephalopathy","volume":"362","author":"Bass","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaut.2013.07.001_bib107","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1002\/hep.24423","article-title":"Characterization of fecal microbial communities in patients with liver cirrhosis","volume":"54","author":"Chen","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2013.07.001_bib108","doi-asserted-by":"crossref","first-page":"G168","DOI":"10.1152\/ajpgi.00190.2011","article-title":"Linkage of gut microbiome with cognition in hepatic encephalopathy","volume":"302","author":"Bajaj","year":"2012","journal-title":"Am J Physiol Gastrointest Liver Physiol"}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841113000917?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841113000917?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T08:08:04Z","timestamp":1760256484000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896841113000917"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":108,"alternative-id":["S0896841113000917"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2013.07.001","relation":{},"ISSN":["0896-8411"],"issn-type":[{"value":"0896-8411","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of the intestinal microbiome in liver disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2013.07.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}